Parsolex GMP Center, Inc., based in West Lafayette, IN, has announced the approval of the sale of its assets and operations in private transactions, leading to the discontinuation of new engagements. Since 2006, Parsolex has been recognized for its Center of Excellence in Pharmaceutical Development and Manufacturing, serving the community with innovative research and medical treatments.
With a focus on providing high-quality products and solving technical challenges, Parsolex expresses gratitude to its clients, patients, employees, staff, and strategic partners for their dedication in delivering CycloERINE Capsules, USP, 250mg CycloSERINE for continued treatment under the same access method. The company's commitment to excellence in pharmaceutical development remains a cornerstone of its legacy.
Generated from the website